Related references
Note: Only part of the references are listed.Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling
Alexander Samoshkin et al.
SCIENTIFIC REPORTS (2015)
Differing roles of autophagy in HIV-associated neurocognitive impairment and encephalitis with implications for morphine co-exposure
Seth M. Deyer et al.
FRONTIERS IN MICROBIOLOGY (2015)
Differential Regulation of 6-and 7-Transmembrane Helix Variants of μ-Opioid Receptor in Response to Morphine Stimulation
Marino Convertino et al.
PLOS ONE (2015)
Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals
Seth M. Dever et al.
AIDS (2014)
A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia
Nazira El-Hage et al.
AIDS (2013)
Opiate Drug Use and the Pathophysiology of NeuroAIDS
Kurt F. Hauser et al.
CURRENT HIV RESEARCH (2012)
Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types
Seth M. Dever et al.
JOURNAL OF NEUROVIROLOGY (2012)
The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment
Benjamin B. Gelman et al.
PLOS ONE (2012)
Physical and functional interaction between CB1 cannabinoid receptors and β2-adrenoceptors
Brian D. Hudson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism
Pavel Gris et al.
MOLECULAR PAIN (2010)
Expansion of the human μ-opioid receptor gene architecture: novel functional variants
Svetlana A. Shabalina et al.
HUMAN MOLECULAR GENETICS (2009)
Diversity and complexity of the mu opioid receptor gene: Alternative pre-mRNA splicing and promoters
YX Pan
DNA AND CELL BIOLOGY (2005)
Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat
N El-Hage et al.
GLIA (2005)
Heterodimerization and cross-desensitization between the μ-opioid receptor and the chemokine CCR5 receptor
CG Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Olfactory receptor surface expression is driven by association with the β2-adrenergic receptor
C Hague et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease
S Morgello et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2001)
Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro
JA Gurwell et al.
NEUROSCIENCE (2001)
Share Paper
